Indian Pantoprazole Exporters: Complete Supplier Ranking with Market Share — 1893 Manufacturers (2026) — TransData Nexus

Q: Who is the largest pantoprazole buyer importing from India?

MYLAN PHARMACEUTICALS INC, (UNITED STATES) is the largest pantoprazole importer from India with a 61.4% market share and import value of $821.9M.

Q: How many pantoprazole buyers import from India?

There are 1893 active pantoprazole buyers importing from India, with a combined import market of $1.3B across 11,610 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top pantoprazole buyers from India?

The top 5 pantoprazole buyers — MYLAN PHARMACEUTICALS INC,, APL SWIFT SERVICES (MALTA) LTD.,, MYLAN PHARMACEUTICALS ULC.,,, EUGIA US LLC, YUSEN LOGISTICS BENELUX BELGIUM — together control 80.0% of total pantoprazole import value from India.

Suresh Sormare

Pantoprazole

India Pharmaceutical Trade Intelligence

$1.3B744 Suppliers154 CountriesHS 30049039

ExportsIndia → UNITED STATES68.3%India → MALTA12.6%

ImportsGERMANY → India$152.4K BRAZIL → India$68.7K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN PHARMACEUTICALS

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $914.6M through 743 shipments. This represents a market share of 68.3% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• MYLAN PHARMACEUTICALS INC, - $821.9M (89.9% of country's total business)

• EUGIA US LLC - $18.8M (2.1% of country's total business)

• MYLAN PHARMACEUTICALS INC - $11.1M (1.2% of country's total business)

• TORRENT PHARMA INC - $8.8M (1.0% of country's total business)

• AUROLOGISTIC LLC,(AUROMEDICS PHARMA - $5.5M (0.6% of country's total business)

• Rest of United States's importers - $48.6M (5.3% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $1.2M, indicating premium pricing strategy compared to the market average of $115.3K.

United States is a key market for Pantoprazole imports, representing 68.3% of total trade value.

Primary Market

Secondary Market

Buyer Segment Analysis

TransData Nexus Pantoprazole buyer market intelligence

1Buyer Segment Analysis

Pantoprazole, a proton pump inhibitor used to treat gastrointestinal conditions, is imported from India by a diverse array of buyers, which can be categorized as follows:

1. Pharmaceutical Companies: Entities such as MYLAN PHARMACEUTICALS INC. (United States, $821.87M), APL SWIFT SERVICES (MALTA) LTD. (Malta, $160.72M), and MYLAN PHARMACEUTICALS ULC. (Canada, $53.45M) are prominent buyers. These companies typically procure large volumes to supply both domestic and international markets, often engaging in long-term contracts to ensure consistent supply chains.

2. Contract Manufacturers: Companies like EUGIA US LLC (United States, $18.80M) and AUROLOGISTIC LLC (AUROMEDICS PHARMA) (United States, $5.48M) fall into this category. They import Pantoprazole for formulation and packaging, catering to various pharmaceutical brands. Their purchasing patterns are influenced by production schedules and client demands, leading to variable order sizes.

3. Distributors and Logistics Providers: Entities such as YUSEN LOGISTICS BENELUX BELGIUM (Belgium, $15.89M) act as intermediaries, facilitating the movement of Pantoprazole from manufacturers to end-users. Their procurement is characterized by moderate volumes, aligning with market demand and inventory turnover rates.

4. Retail Chains and Pharmacies: HEKO PHARMACY LTD (Tanzania, $15.43M) represents this segment, importing Pantoprazole to meet consumer demand in retail settings. Their purchasing behavior is typically steady, reflecting consistent consumer needs and prescription trends.

5. Re-exporters: Some buyers may import Pantoprazole with the intent to re-export to other markets, leveraging trade agreements and regional demand. Their order patterns can be sporadic, influenced by external market opportunities and regulatory environments.

Country-Specific Import Regulations

TransData Nexus Pantoprazole buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries of Pantoprazole from India, the import regulations are as follows:

1. United States:

Regulatory Authority: U.S. Food and Drug Administration (FDA).

Import Registration Process: The FDA requires that imported pharmaceuticals be manufactured in facilities compliant with Good Manufacturing Practices (GMP). Importers must submit a New Drug Application (NDA) or an Abbreviated New Drug Application (ANDA) for generic drugs.

Estimated Timeline: The approval process can range from 10 months to several years, depending on the complexity of the application and the FDA's review workload.

Import Tariff/Duty: Pharmaceutical products under HS Code 30049039 are generally duty-free, but importers should verify current tariffs with U.S. Customs and Border Protection.

2. Malta:

Regulatory Authority: Malta Medicines Authority.

Demand Drivers & Market Opportunity

TransData Nexus Pantoprazole buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Pantoprazole in importing countries is driven by several factors:

1. Disease Prevalence: Gastrointestinal disorders, such as gastroesophageal reflux disease (GERD) and peptic ulcers, are prevalent globally. The increasing incidence of these conditions, often linked to lifestyle factors and aging populations, fuels the demand for effective treatments like Pantoprazole.

2. Government Healthcare Programs: Many countries have implemented healthcare initiatives aimed at improving access to essential medicines. For instance, the inclusion of Pantoprazole in national formularies and reimbursement schemes enhances its availability and affordability.

3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage (UHC) have led to increased procurement of essential medicines. Countries expanding their UHC programs prioritize the availability of cost-effective treatments for common conditions, thereby boosting demand for generic drugs like Pantoprazole.

4. WHO Essential Medicines List Procurement: The World Health Organization's Model List of Essential Medicines serves as a guideline for countries to develop their own essential medicines lists. Inclusion in this list often leads to increased procurement by public health systems, ensuring that vital medications are accessible to the population.

5. Tender-Based Purchasing: Many governments and large healthcare providers utilize tender systems to procure pharmaceuticals, aiming to secure the best prices through competitive bidding. This approach not only drives demand but also influences market dynamics by encouraging manufacturers to offer competitive pricing and maintain high-quality standards.

With 1,893 buyers across 154 countries, the global market for Pantoprazole presents significant opportunities. Manufacturers and exporters can leverage these demand drivers by aligning their strategies with the healthcare priorities and procurement practices of importing countries.

Common Questions — Pantoprazole Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest pantoprazole buyer importing from India?

Based on import volume and value, MYLAN PHARMACEUTICALS INC, (UNITED STATES) leads with $821.9M in imports and a 61.4% market share — the highest of any single pantoprazole importer. APL SWIFT SERVICES (MALTA) LTD., (MALTA) and MYLAN PHARMACEUTICALS ULC.,, (CANADA) are the next largest buyers.

QHow many companies buy pantoprazole from India?

There are 1893 active pantoprazole buyers importing from India, with a combined market of $1.3B across 11,610 shipments to 154 countries. The top 5 buyers hold 80.0% of total import value, while the remaining 1888 buyers handle the other 20.0%.

QWhich countries import the most pantoprazole from India?

The top importing countries for pantoprazole from India are United States (68.3%), Malta (12.6%), Canada (6.3%), Belgium (1.3%), Tanzania (1.2%). These markets represent the largest demand centres for Indian pharmaceutical exports of pantoprazole, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for pantoprazole from India?

The average import transaction value for pantoprazole from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Pantoprazole buyer market intelligence

1Buyer Segment Analysis

Pantoprazole, a proton pump inhibitor used to treat gastrointestinal conditions, is imported from India by a diverse array of buyers, which can be categorized as follows:

Country-Specific Import Regulations

TransData Nexus Pantoprazole buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries of Pantoprazole from India, the import regulations are as follows:

1. United States:

Regulatory Authority: U.S. Food and Drug Administration (FDA).

Estimated Timeline: The approval process can range from 10 months to several years, depending on the complexity of the application and the FDA's review workload.

Import Tariff/Duty: Pharmaceutical products under HS Code 30049039 are generally duty-free, but importers should verify current tariffs with U.S. Customs and Border Protection.

2. Malta:

Regulatory Authority: Malta Medicines Authority.

Demand Drivers & Market Opportunity

TransData Nexus Pantoprazole buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Pantoprazole in importing countries is driven by several factors:

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Pantoprazole

Pantoprazole

Who Buys Pantoprazole from India — 1893 Importers Behind a $1.3B Market

Top Pantoprazole Importers — Ranked by Import Value

Top Pantoprazole Buyers & Importers

Related Analysis

Need Details?

Pantoprazole — Export Intelligence Video

Market Analysis: Top Importing Countries & Importers

Which companies are buying Pantoprazole — and from which countries?

Pantoprazole — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United States

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Pantoprazole Buyers & Importers

QWho is the largest pantoprazole buyer importing from India?

QHow many companies buy pantoprazole from India?

QWhich countries import the most pantoprazole from India?

QWhat is the average import order value for pantoprazole from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

2Malta

3Canada

4Belgium

5Tanzania

Analysis Methodology